The development of highly sensitive and reliable biosensing platforms is essential for the detection of trace-level biomarkers in clinical and environmental applications. In this study, we present a solid-state plasmonic hot-carrier biosensor for the ...
The development of highly sensitive and reliable biosensing platforms is essential for the detection of trace-level biomarkers in clinical and environmental applications. In this study, we present a solid-state plasmonic hot-carrier biosensor for the ultrasensitive detection of 17β-estradiol (E2), a potent endogenous estrogen hormone involved in the regulation of the endocrine system. The proposed device is based on an Au/Si/Au optoelectronic architecture integrated with gold nanoparticles (GNPs) functionalized through a biorecognition interface involving antibody and aptamer components. Under resonant optical excitation, localized surface plasmon resonance (LSPR) in the GNPs generates energetic charge carriers via non-radiative decay processes, which can be injected across the Au/Si interface to produce a measurable photocurrent. The presence of E2 modulates the interfacial electronic environment and influences carrier transport, resulting in a concentration-dependent photocurrent response. The effects of nanoparticle distribution, plasmonic field enhancement, and interfacial energetics on device performance are systematically investigated. The proposed biosensor demonstrates ultrasensitive detection with a limit of detection of approximately 13 aM, indicating its capability for trace-level hormone sensing. These results indicate that plasmonic hot-carrier injection can serve as an effective transduction mechanism for label-free biosensing, enabling the development of miniaturized optoelectronic sensing platforms.